Heme Foundation FY2023 filing

Tax-deductible

Walnutport, PA501(c)(3)Medical ResearchEIN 85-2693882

Develop a drug that acts as a blood substitute oxygenation drug readily available in unlimited supply.

501(c)(3) charity; gifts are tax-deductible.
56¢ of each $1 spent went to programs.
$171K paid to officers and key staff.
Mission: Form 990 Part I, line 1 · Status: IRS Pub. 78 · Programs: Part IX · Pay: Part VII

Before you give

FY2023 · Form 990Independent: from IRS data, not the org
Download 990
IRS status
501(c)(3)
not on the IRS revocation list
Looks good: listed by the IRS and not on the revocation list.
IRS BMF · Auto-Revocation List
Tax-deductible gifts
Yes
Donations are tax-deductible
Looks good: the IRS lists gifts to it as deductible.
IRS Pub. 78 · IRS BMF
Latest return
FY2024
latest Form 990
Looks good: the latest return is for FY2024, 2 tax years back; within 2 tax years.
IRS e-file · Filing history
Surplus or deficit
1 of 2
filings with a surplus
Average surplus $574K a year · 63% of revenue · last 2 filings
Worth a look: a surplus in 1 of the last 2 filings.
Pt I · Ln 19 · 2 filings
Spent on programs
56%
of spending
Worth a look: 56% of spending went to programs; under 65%.
Pt IX · Ln 25 · col B
Pay to officers and key staff
$171K
to officers and key staff · 85% of spending
Concern: pay to officers and key staff is 85% of spending; over 30%.
Pt VII · Sec A
Cash reserves
1 mo
of spending, in cash
Fine: 1.0 months of spending in cash; 1 to 3.
Pt X · Ln 1–2 · Pt I · Ln 18
Liabilities
$0
0% of total assets
Looks good: liabilities are 0% of assets; 50% or less.
Pt X · Ln 26
Independent board members
3
of 3 voting members
Looks good: 3 of 3 voting members are independent, a majority.
Pt VI · Ln 1a–1b
Looks goodFineWorth a lookConcernNo data yetTap a box for the reason.
Revenue
$1.5M
Spent
$200K
To programs
56%
Net assets
$460K
By yearFY2023–FY2024
Revenue
$1.5M
FY2023
Revenue by fiscal year
FY2023$1.5M
FY2024$342K
Expenses
$200K
FY2023
Expenses by fiscal year
FY2023$200K
FY2024$467K
Net assets
$460K
FY2023
Net assets by fiscal year
FY2023$460K
FY2024$286K

From the FY2023 Form 990 · see the original

Give Claim
You’re viewing the FY2023 filing — not the latest on file. See the latest (FY2024) →

Status and standing

Is it real, and can you give to it?

Tax-deductible?
Yes
Per the IRS master file.
Can I give now?
No revocation on IRS record
Not on the IRS revocation list.
Filing up to date?
Filed FY2024 (typical filing lag)
Legal name (IRS)Hdr · item CHeme Foundation
EINHdr · item D85-2693882
Exempt statusHdr · item I501(c)(3) · active
Ruling yearIRS BMFApr 2022
Latest filingForm 990FY2024 · Form 990
Principal addressHdr · item CWalnutport, PA
NTEE classificationIRS BMFMedical Research (H99)
WebsiteHdr · item Jhemefoundation.org

Where the money goes

What each dollar paid for.

Statement of Functional Expenses

Part IX · allocated across program, management, and fundraising
Allocation · columns B–D
Program services $0.56 Management & general $0.44 Fundraising $0.77
Program services56%$113K
Management & general44%$88K
Fundraising77%$154K
Total functional expensesLn 25$200K

Financial health

Is it on solid ground?

Program efficiency
56%
of spending reaches programs
Operating runway
23.7mo
months of highly liquid reserves at operating expense rate
Surplus margin
+86%
revenue over expenses, this year

Summary of the Filing

Part I · fiscal year 2023 · Form 990
Total assets
$460K
FY2023
Total assets by fiscal year
FY2023$460K
FY2024$288K
Total liabilities
$0
FY2023
Total liabilities by fiscal year
FY2023$0
FY2024$3K
Revenue less expensesPt I · Ln 19$1.3M
Total assetsPt X · Ln 16$460K
Program-expense ratioPt IX · col B56%
Voting members of governing bodyPt I · Ln 33
Independent voting membersPt I · Ln 43

Balance Sheet

Part X · end of year
CashLn 1$17K
Total assetsLn 16$460K
Total liabilitiesLn 26$0
Total net assetsLn 32$460K
Months of cash on handcomputed1.0

Statement of Revenue

Part VIII
Contributions & grants136%$2.0M
Total revenueLn 12$1.5M

Financial Metrics

Form 990 · FY2023 · each ratio shown with the dollars behind it
Liquidity & Payout
Operating runway
Highly liquid reserves $396K · Operating expenses/yr $200K
23.7 months
Where the money goes
Program services
Program services $113K · Total expenses $200K
56%
Management & General
Management & general $88K · Total expenses $200K
44%
Fundraising
Fundraising $0 · Total expenses $200K
0%
Cost to raise $1
Fundraising expense $0 · Solicited contributions $2.0M
Solicited contributions below reporting floor
Where the money comes from
Contribution dependence
Contributions & grants $2.0M · Total revenue $1.5M
136%
Government reliance
Government grants — · Total revenue $1.5M
—
Earned-income share
Program service revenue $0 · Total revenue $1.5M
0%
Investment reliance
Investment income −$525K · Total revenue $1.5M
-36%
Program self-sufficiency
Program service revenue $0 · Total expenses $200K
0%
Growth & trend
Revenue growth (YoY)
This year $1.5M · Prior year —
No prior year on file
Net-asset trend (YoY)
End of year $460K · Beginning of year —
Beginning net assets not meaningfully positive — showing dollar change
Balance sheet
Surplus Margin
Revenue $1.5M · Expenses $200K
+86%
Liabilities-to-Assets
Total liabilities — · Total assets $460K
—
Net-asset ratio
Net assets $460K · Total assets $460K
100%
Marketable Investment Share
Publicly traded securities (Pt X, ln 11) $379K · Other securities (Pt X, ln 12) — · Total assets (Pt X, ln 16) $460K
82%
People & payroll
Highest Reported Total Compensation
Individual Jonathan Barkman · Reported title BOARD CHAIR · Highest reported compensation $85K · Total expenses $200K
43%
Personnel share
Salaries, benefits & payroll (Pt IX 5-10) $92K · Total expenses $200K
46%
Peer comparison

Same NTEE category, revenue band, and state where available. Descriptive — not a grade.

MetricThis orgPeer medianPercentile
Program ratio 56%——
Overhead ratio 44%——
Fundraising cost ratio 8%——
Legal fee ratio 5%——
Accounting fee ratio 1.0%——

Straight from the Form 990 — descriptive, not an evaluation. A ratio is hidden when its base is zero or too small to be meaningful; the dollars are always shown.

Leadership and pay

Who runs it, and what are they paid?

Officers, Directors & Key Employees

Part VII, Section A · reportable compensation
Board Chair
$85,369Pt VII · Sec A
Board Chair
$85,369Pt VII · Sec A
Board Member
$0Pt VII · Sec A
Board Member
$0Pt VII · Sec A
Board Member
$0Pt VII · Sec A
Board Member
$0Pt VII · Sec A
Board Member
$0Pt VII · Sec A
Secretary
$0Pt VII · Sec A

Jonathan Barkman’s $134K as Board Chair is at the 85th percentile of top reported officer pay among 328 $100K–1M medical research nonprofits. Peer set: organizations in the same NTEE major field of work and revenue-size band, compared on each org’s own highest-paid officer/key-employee, from Form 990 Part VII / 990-PF Part VIII. Descriptive placement, not a verdict on whether the pay is appropriate.

Compensation history total reportable pay by year · 1 named individual · Part VII

NameFY2024FY2023
Jonathan Barkman$134,008$85,369

Total reportable compensation (Form 990 Part VII column D / Schedule J column E) by filing year, matched by name within this organization. The Schedule J base / bonus / deferred breakdown is not parsed into this dataset.

See Heme Foundation executive salaries →

Are you one of these people? Claim this org to confirm your role

Governance & Policies

Part VI
  • 3Voting board membersPt VI · Ln 1a
  • 3Independent board membersPt VI · Ln 1b
  • Conflict-of-interest policyPt VI · Ln 12aYes
  • Whistleblower policyPt VI · Ln 13No
  • Document retention policyPt VI · Ln 14Yes
  • Top official’s pay independently reviewedPt VI · Ln 15aNo
  • Family or business ties among leadersPt VI · Ln 2No

Mission and programs

What it does.

Develops a drug to substitute for blood, providing oxygen readily.

Provided by the organization

This section is blank until Heme Foundation claims this page.

Know this organization? Claim it to add your story

Mission & Programs · Part III

Where the work happens

2 program services account for $116K of program spending, described in the organization's own filed words · FY2023.
01

Develop a drug that acts as a blood substitute oxygenation drug readily available in unlimited supply.

$113Kprogram expense
02

Develop a drug that acts as a blood substitute oxygenation drug readily available in unlimited supply.

$4Kprogram expense

Run this program? Claim this org to tell your story

Filing history

Every return on file.

YearRevenueExpensesChangeFiling
FY2024 Latest $342K$467K-77% 990 PDF
FY2023 Viewing $1.5M$200K 990 PDF

Want to add your own materials alongside these filings? Claim this org

Schedules filed Part IV

III · Programs I · Grants R · Related orgs G · Fundraising L · Interested persons A · Public support F · Foreign M · Noncash

Not shown yet: ratings, outcomes, and peer benchmarks. A Form 990 doesn’t report them.

Similar organizations you could support

Closest in mission — by what they do
See all organizations like Heme Foundation →

Run this organization? Claim this page

Compare

Search another nonprofit to view revenue, expenses, assets, key metrics, and leaders side by side

Sources

Every figure above is drawn from these filings
Form 990 e-file (XML) · FY2023IRS
Classification, formation year, addressIRS Business Master File
Names, privacy, and removal requests More

The names, titles, and compensation shown on this page are reproduced from IRS Form 990 filings, which are public records.

Philanthropy.org does not alter the content of those filings. All information appears exactly as reported by the filing organization for the tax year shown.

We publish only information contained in the public IRS filing — and less than the filing contains. Our profile pages do not display street addresses, telephone numbers, personal email addresses, or other personal contact information, even where the filing includes them.

Many people share the same name. A name shown on this page reflects only what one organization reported in one IRS filing for one tax year. It should not be interpreted as identifying any other individual with the same or a similar name.

If you are no longer affiliated with the organization, your name will generally stop appearing in future IRS filings once the organization no longer reports you. Pages for tax years in which you were reported remain published because those filings remain part of the public record.

Philanthropy.org does not alter or remove IRS filing records. Removing a page from this website would not remove the underlying IRS filing, which remains publicly available from the IRS and other publishers of the same information.

If you believe the IRS filing itself is inaccurate, corrections must be made by the filing organization or the IRS directly.

If you ARE the filing organization, claim this org and add context

Made it to the end? Claim this organization

Keep this kind of thing free
Keep public charity data easy to read.

Free to the public, because obviously. Like this? Pay it forward. Don't like this? Help us get better.

Card, Apple Pay or Google Pay through Stripe. One time.
Keep this kind of thing free
Keep public charity data easy to read.

Free to the public, because obviously. Like this? Pay it forward. Don't like this? Help us get better.

Card, Apple Pay or Google Pay through Stripe. One time.

All figures are derived from public IRS Form 990 filings and are presented without evaluation of any organization. philanthropy.org does not rate, score, or rank organizations, including the peer-cohort and compensation comparisons above.